Oncimmune Holdings plc (AIM:ONC)

Market Cap	1.27M
Revenue (ttm)	2.74M
Net Income (ttm)	-3.63M
Shares Out	111.77M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	406,954
Average Volume	565,514
Open	1.390
Previous Close	1.190
Day's Range	1.010 - 1.390
52-Week Range	0.011 - 31.000
Beta	1.81
RSI	21.13
Earnings Date	May 23, 2025

About Oncimmune Holdings

Oncimmune Holdings plc, a precision medicine company, provides autoantibody biomarker profiling in immuno-oncology, autoimmune, and infectious diseases in Europe and internationally. The company offers ImmunoINSIGHTS platform, an autoantibody profiling service that provides insights to discover and validate novel biomarkers, validate drug mode of action, improve treatment responses and adverse event (irAE) prediction, patient screening, and diagnostic accuracy; Sero Tag, a discovery engine for the identification of relevant biomarker pool for t...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2015
• Employees: 40
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: ONC